TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients

References

• Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49:511–533.
   PubMed Web of Science ®Google Scholar
• Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–1826. doi: 10.1056/NEJMra052638
   PubMed Web of Science ®Google Scholar
• Locatelli F, Vinti L, Palumbo G, et al. Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2011;24:339–349. doi: 10.1016/j.beha.2011.04.004
   PubMed Web of Science ®Google Scholar
• Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767–1777.
   PubMed Web of Science ®Google Scholar
• Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985;13:765–771. doi: 10.1056/NEJM198509263131301
   Web of Science ®Google Scholar
• Koh LP, Chao N. Haploidentical hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42:S60–S63. doi: 10.1038/bmt.2008.117
   PubMedGoogle Scholar
• Munchel AT, Kasamon YL, Fuchs EJ. Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide. Best Pract Res Clin Haematol. 2011;24:359–368. doi: 10.1016/j.beha.2011.05.001
   PubMed Web of Science ®Google Scholar
• Liu H, Rich ES, Godley L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438–6445. doi: 10.1182/blood-2011-08-372508
   PubMed Web of Science ®Google Scholar
• Locatelli F, Vinti L, Palumbo G, et al. Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2011;24:339–349. doi: 10.1016/j.beha.2011.04.004
   PubMed Web of Science ®Google Scholar
• Fuchs EJ. Haploidentical transplantation for hematologic malignancies: where do we stand? Hematology Am Soc Hematol Educ Program. 2012;2012:230–236.
   PubMedGoogle Scholar
• Chang Y-J, Zhao X-Y, Huang X-Y. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:440–449. doi: 10.1016/j.bbmt.2013.11.028
   PubMed Web of Science ®Google Scholar
• Lang P, Feuchtinger T, Teltschik HM, et al. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients. Bone Marrow Transplant. 2015;50(Suppl. 2):S6–S10. doi: 10.1038/bmt.2015.87
   PubMedGoogle Scholar
• Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304. doi: 10.1097/00007890-197410000-00001
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–956. doi: 10.1016/j.bbmt.2005.09.004
   PubMed Web of Science ®Google Scholar
• Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 2011;118:6006–6017. doi: 10.1182/blood-2011-07-338822
   PubMed Web of Science ®Google Scholar
• Feuchtinger T, Teltschik HM, Schumm M, et al. Transplantation of TcRαβ/CD19 depleted stem cells from haploidentical donors in children: current results. Blood. 2013;122:692.
   Web of Science ®Google Scholar
• Federmann B, Bornhauser M, Meisner C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica. 2012;97:1523–1531. doi: 10.3324/haematol.2011.059378
   PubMed Web of Science ®Google Scholar
• Chen R, Campbell JL, Chen B. Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation. Onco Targets Ther. 2015;8:405–412. doi: 10.2147/OTT.S78567
   PubMed Web of Science ®Google Scholar
• Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 2008;112:4371–4383. doi: 10.1182/blood-2008-03-077974
   PubMed Web of Science ®Google Scholar
• Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555–562.
   PubMed Web of Science ®Google Scholar
• Stern M, Ruggeri L, Mancusi A, et al. Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood. 2008;112:2990–2995. doi: 10.1182/blood-2008-01-135285
   PubMed Web of Science ®Google Scholar
• Alpdogan O, Grosso D, Flomenberg N. Recent advances in haploidentical stem cell transplantation. Discov Med. 2013;16:159–165.
   PubMed Web of Science ®Google Scholar
• Verneris MR. Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL. Hematol Am Soc Hematol Educ Program. 2013;2013:335–341.
   PubMedGoogle Scholar
• Bayraktar UD, Ciurea SO. Strategies in haploidentical stem cell transplantation in adults. Turk J Hematol. 2013;30:342–350. doi: 10.4274/Tjh.2013.0054
   PubMed Web of Science ®Google Scholar
• Solomon SR, Sizemore C, Sanacore M, et al. Total Body Irradiation-based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors. Blood. 2015;21:1299–1307.
   Web of Science ®Google Scholar
• Piemontese S, Ciceri F, Labopin M, et al. Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT). A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia. Leukemia. 2015;29:1069–1075. doi: 10.1038/leu.2014.336
   PubMed Web of Science ®Google Scholar